Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
CNS Drugs|April 16, 2021
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.Schizophrenia Research|August 16, 2014
Cortical thinning and caudate abnormalities in first episode psychosis and their association with clinical outcomeCathy Scanlon, Heike Anderson-Schmidt, Liam Kilmartin, et al.Depression and Anxiety|February 2, 2021
Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessmentYuri E Rybak, Ka S P Lai, Rajamannar Ramasubbu, et al.Journal of Affective Disorders|October 28, 2021
Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study reportKaterina Rnic, Young-Eun Jung, Ivan Torres, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 17, 2022
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive DisorderSmadar V Tourjman, Gabriella Buck, Didier Jutras-Aswad, et al.BMJ Open|April 15, 2021
How do delirium motor subtypes differ in phenomenology and contributory aetiology? a cross-sectional, multisite study of liaison psychiatry and palliative care patientsKevin Glynn, Frank McKenna, Kevin Lally, et al.The Journal of Clinical Psychiatry|March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 ReportSidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.Pageof 2